• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Unity Software To Rally Around 60%? Here Are 10 Other Analyst Forecasts For Friday

    9/15/23 7:17:32 AM ET
    $ADBE
    $APLS
    $BLRX
    $EL
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADBE alert in real time by email
    • B of A Securities raised the price target for Unity Software Inc. (NYSE:U) from $46 to $56. B of A Securities analyst Ryan Gee upgraded the stock from Neutral to Buy. Unity Software shares fell 3% to close at $35.71 on Thursday.
    • Truist Securities boosted Vornado Realty Trust (NYSE:VNO) price target from $22 to $27. Truist Securities analyst Michael Lewis downgraded the stock from Buy to Hold. Vornado Realty Trust shares gained 2.9% to close at $25.24 on Thursday.
    • Needham cut the price target for STAAR Surgical Company (NASDAQ:STAA) from $54 to $52. Needham analyst David Saxon maintained a Buy rating. STAAR Surgical shares fell 1.8% to $42.08 in pre-market trading.
    • HC Wainwright & Co. raised the price target for BioLineRx Ltd. (NASDAQ:BLRX) from $19 to $21. HC Wainwright & Co. analyst Joseph Pantginis maintained a Buy rating. BioLineRx shares rose 1.1% to $1.78 in pre-market trading.
    • Piper Sandler raised Adobe Inc. (NASDAQ:ADBE) price target from $572 to $650. Piper Sandler analyst Brent Bracelin maintained an Overweight rating. Adobe shares fell 1.9% to $541.75 in pre-market trading.
    • Piper Sandler raised KeyCorp (NYSE:KEY) price target from $ $12 to $13.5. Piper Sandler analyst Scott Siefers upgraded the stock from Neutral to Overweight. KeyCorp shares rose 1.7% to $11.85 in pre-market trading.
    • Wells Fargo increased Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) price target from $34 to $64. Wells Fargo analyst Derek Archila upgraded the stock from Equal-Weight to Overweight. Apellis Pharmaceuticals shares gained 3.3% to $44.73 in pre-market trading.
    • Redburn Atlantic cut The Estée Lauder Companies Inc. (NYSE:EL) price target from $160 to $150. Redburn Atlantic analyst Chris Pitcher upgraded the stock from Sell to Neutral. Estée Lauder shares rose 1.1% to $156.00 in pre-market trading.
    • Stifel cut the price target for Lindsay Corporation (NYSE:LNN) from $146 to $135. Stifel analyst Nathan Jones downgraded the stock from Buy to Hold. Lindsay shares rose 2.9% to close at $127.83 on Thursday.
    • DA Davidson cut New Relic, Inc. (NYSE:NEWR) price target from $95 to $87. DA Davidson analyst Gil Luria downgraded the stock from Buy to Neutral. New Relic shares fell 0.1% to close at $85.40 on Thursday.
    • Goldman Sachs boosted MorphoSys AG (NASDAQ:MOR) price target from $3.5 to $9.25. Goldman Sachs analyst Rajan Sharma upgraded the stock from Sell to Neutral. MorphoSys shares rose 1.4% to $8.07 in pre-market trading.

    Check This Out: Stitch Fix Likely To Narrower Q4 Loss; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts

    Get the next $ADBE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADBE
    $APLS
    $BLRX
    $EL

    CompanyDatePrice TargetRatingAnalyst
    Estee Lauder Companies Inc.
    $EL
    2/10/2026$106.00Buy → Hold
    HSBC Securities
    Unity Software Inc.
    $U
    2/10/2026$38.00Perform → Outperform
    Oppenheimer
    Estee Lauder Companies Inc.
    $EL
    2/6/2026$120.00Neutral → Buy
    Citigroup
    STAAR Surgical Company
    $STAA
    2/3/2026$26.00Neutral
    Wedbush
    Adobe Inc.
    $ADBE
    2/3/2026$330.00Overweight → Neutral
    Piper Sandler
    Apellis Pharmaceuticals Inc.
    $APLS
    1/28/2026$24.00Equal Weight
    Barclays
    Apellis Pharmaceuticals Inc.
    $APLS
    1/21/2026$28.00Neutral → Buy
    BofA Securities
    STAAR Surgical Company
    $STAA
    1/16/2026$13.00Underweight
    Morgan Stanley
    More analyst ratings

    $ADBE
    $APLS
    $BLRX
    $EL
    SEC Filings

    View All

    SEC Form 10-K filed by Unity Software Inc.

    10-K - Unity Software Inc. (0001810806) (Filer)

    2/11/26 7:03:35 AM ET
    $U
    Computer Software: Prepackaged Software
    Technology

    Unity Software Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Unity Software Inc. (0001810806) (Filer)

    2/11/26 7:01:01 AM ET
    $U
    Computer Software: Prepackaged Software
    Technology

    Unity Software Inc. filed SEC Form 8-K: Leadership Update

    8-K - Unity Software Inc. (0001810806) (Filer)

    2/10/26 4:39:08 PM ET
    $U
    Computer Software: Prepackaged Software
    Technology

    $ADBE
    $APLS
    $BLRX
    $EL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Unity Reports Fourth Quarter and Fiscal Year 2025 Financial Results

    Unity (NYSE:U), the world's leading game engine, today announced financial results for the fourth quarter and fiscal year ended December 31, 2025. "Fourth quarter results once again comfortably exceeded the high-end of our guidance, led by exceptional performance from Vector, which experienced its third consecutive quarter of mid-teen sequential revenue growth, and the best growth we've seen in Create in over two years," said Matt Bromberg, President and CEO of Unity. "With Vector demonstrating rapid growth and Unity 6 adoption at the fastest rate we've ever experienced, our goal of becoming the essential infrastructure for the next generation of interactive entertainment is coming into

    2/11/26 7:00:00 AM ET
    $U
    Computer Software: Prepackaged Software
    Technology

    Unity Appoints Bernard Kim to its Board of Directors and Announces Board Transitions

    Unity (NYSE:U), the world's leading game engine, today announced the appointment of gaming and technology veteran Bernard Kim as an independent director to its Board of Directors, effective May 1, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260210709281/en/Bernard Kim "Bernard brings deep experience building and scaling global, public companies at the intersection of games and technology," said Jim Whitehurst, Chairman of Unity's Board of Directors. "His leadership across mobile gaming, advertising technology, and consumer platforms will be a valuable addition to the Unity Board." "Unity plays a foundational role in h

    2/10/26 4:15:00 PM ET
    $U
    Computer Software: Prepackaged Software
    Technology

    Apellis Pharmaceuticals to Host Conference Call on February 24, 2026, to Discuss Fourth Quarter and Full Year 2025 Financial Results

    WALTHAM, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) today announced that the company will host a conference call and webcast to discuss its fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026 at 8:30 a.m. ET. To access the live call by phone, please pre-register for the call here. A live audio webcast of the event and accompanying slides may also be accessed through the "Events and Presentations" page of the "Investors and Media" section of the company's website. A replay of the webcast will be available for 30 days following the event. About Apellis Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company

    2/10/26 7:00:00 AM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADBE
    $APLS
    $BLRX
    $EL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Broadwood Partners, L.P. bought $606,138 worth of shares (27,485 units at $22.05) (SEC Form 4)

    4 - STAAR SURGICAL CO (0000718937) (Issuer)

    1/13/26 9:30:12 PM ET
    $STAA
    Ophthalmic Goods
    Health Care

    Large owner Broadwood Partners, L.P. bought $8,817,664 worth of shares (406,653 units at $21.68) (SEC Form 4)

    4 - STAAR SURGICAL CO (0000718937) (Issuer)

    1/8/26 7:31:31 PM ET
    $STAA
    Ophthalmic Goods
    Health Care

    Large owner Broadwood Partners, L.P. bought $41,060,317 worth of shares (1,500,000 units at $27.37) (SEC Form 4)

    4 - STAAR SURGICAL CO (0000718937) (Issuer)

    11/21/25 9:55:23 PM ET
    $STAA
    Ophthalmic Goods
    Health Care

    $ADBE
    $APLS
    $BLRX
    $EL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Wang Christopher Min Fang claimed ownership of 3,257,130 shares (SEC Form 3)

    3 - STAAR SURGICAL CO (0000718937) (Issuer)

    2/10/26 7:43:52 PM ET
    $STAA
    Ophthalmic Goods
    Health Care

    Director Bank Of Nova Scotia returned $9,328,039 worth of shares to the company (415,133 units at $22.47), decreasing direct ownership by 0.26% to 160,907,941 units (SEC Form 4)

    4 - KEYCORP /NEW/ (0000091576) (Issuer)

    2/10/26 7:19:02 PM ET
    $KEY
    Major Banks
    Finance

    Head of Institutional Bank Paine Andrew J Iii sold $1,532,274 worth of shares (65,961 units at $23.23), decreasing direct ownership by 28% to 166,583 units (SEC Form 4)

    4 - KEYCORP /NEW/ (0000091576) (Issuer)

    2/10/26 5:01:38 PM ET
    $KEY
    Major Banks
    Finance

    $ADBE
    $APLS
    $BLRX
    $EL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $ADBE
    $APLS
    $BLRX
    $EL
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    Estee Lauder downgraded by HSBC Securities with a new price target

    HSBC Securities downgraded Estee Lauder from Buy to Hold and set a new price target of $106.00

    2/10/26 7:59:21 AM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary

    Unity Software upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded Unity Software from Perform to Outperform and set a new price target of $38.00

    2/10/26 7:17:53 AM ET
    $U
    Computer Software: Prepackaged Software
    Technology

    Estee Lauder upgraded by Citigroup with a new price target

    Citigroup upgraded Estee Lauder from Neutral to Buy and set a new price target of $120.00

    2/6/26 8:05:27 AM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary

    FDA Approval for APHEXDA issued to BIOLINERX, LTD.

    Submission status for BIOLINERX, LTD.'s drug APHEXDA (ORIG-1) with active ingredient MOTIXAFORTIDE has changed to 'Approval' on 09/08/2023. Application Category: NDA, Application Number: 217159, Application Classification: Type 1 - New Molecular Entity

    9/11/23 2:15:50 PM ET
    $BLRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for EMPAVELI issued to APELLIS PHARMACEUTICALS INC

    Submission status for APELLIS PHARMACEUTICALS INC's drug EMPAVELI (ORIG-1) with active ingredient PEGCETACOPLAN has changed to 'Approval' on 05/14/2021. Application Category: NDA, Application Number: 215014, Application Classification: Type 1 - New Molecular Entity

    5/17/21 11:09:40 AM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADBE
    $APLS
    $BLRX
    $EL
    Leadership Updates

    Live Leadership Updates

    View All

    Unity Appoints Bernard Kim to its Board of Directors and Announces Board Transitions

    Unity (NYSE:U), the world's leading game engine, today announced the appointment of gaming and technology veteran Bernard Kim as an independent director to its Board of Directors, effective May 1, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260210709281/en/Bernard Kim "Bernard brings deep experience building and scaling global, public companies at the intersection of games and technology," said Jim Whitehurst, Chairman of Unity's Board of Directors. "His leadership across mobile gaming, advertising technology, and consumer platforms will be a valuable addition to the Unity Board." "Unity plays a foundational role in h

    2/10/26 4:15:00 PM ET
    $U
    Computer Software: Prepackaged Software
    Technology

    STAAR Surgical Appoints Warren Foust and Deborah Andrews Interim Co-CEOs

    Search Committee Has Initiated a Global Search to Select Next CEO STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ:STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that its Board of Directors (the "Board") has appointed Warren Foust, President and Chief Operating Officer, and Deborah Andrews, Chief Financial Officer, as interim co-Chief Executive Officers, effective February 1, 2026. Mr. Foust and Ms. Andrews will work together with the other members of the executive leadership team, with support and guidance from the Board, as they lead the Company and manage its day-to-day operations.

    2/2/26 7:00:00 AM ET
    $STAA
    Ophthalmic Goods
    Health Care

    TTM Technologies, Dutch Bros, Advanced Energy Industries, and American Healthcare REIT Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600

    NEW YORK, Jan. 27, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400, S&P SmallCap 600: S&P SmallCap 600 constituent TTM Technologies Inc. (NASD: TTMI) will replace Civitas Resources Inc. (NYSE:CIVI) in the S&P MidCap 400, and Amneal Pharmaceuticals Inc. (NASD: AMRX) will replace TTM Technologies in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 30. S&P SmallCap 600 constituent SM Energy Co. (NYSE:SM) is acquiring Civitas Resources in a deal expected to be completed soon, pending final closing conditions. SM Energy will remain in the S&P SmallCap 600 post-merger.Dutch Bros Inc. (NYSE:BROS) will replace Potlatc

    1/27/26 6:02:00 PM ET
    $AEIS
    $AHR
    $AMRX
    Industrial Machinery/Components
    Technology
    Real Estate Investment Trusts
    Real Estate

    $ADBE
    $APLS
    $BLRX
    $EL
    Financials

    Live finance-specific insights

    View All

    Apellis Pharmaceuticals to Host Conference Call on February 24, 2026, to Discuss Fourth Quarter and Full Year 2025 Financial Results

    WALTHAM, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) today announced that the company will host a conference call and webcast to discuss its fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026 at 8:30 a.m. ET. To access the live call by phone, please pre-register for the call here. A live audio webcast of the event and accompanying slides may also be accessed through the "Events and Presentations" page of the "Investors and Media" section of the company's website. A replay of the webcast will be available for 30 days following the event. About Apellis Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company

    2/10/26 7:00:00 AM ET
    $APLS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Vornado Declares Quarterly Dividends On Preferred Shares

    NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Vornado Realty Trust (NYSE:VNO) announced today that its Board of Trustees has declared the following quarterly preferred dividends: Series A Convertible$.8125000per shareSeries L Cumulative Redeemable$.3375000per shareSeries M Cumulative Redeemable$.3281250per shareSeries N Cumulative Redeemable$.3281250per shareSeries O Cumulative Redeemable$.2781250per share In each case, dividends are payable on April 1, 2026 to shareholders of record on March 16, 2026. Vornado Realty Trust is a fully-integrated equity real estate investment trust. CONTACT Thomas J. Sanelli(212) 894-7000 Certain statements contained herein may constitute "forward-lookin

    2/5/26 3:52:04 PM ET
    $VNO
    Real Estate Investment Trusts
    Real Estate

    The Estée Lauder Companies Reports Fiscal 2026 Second Quarter Results

    Delivered Strong Fiscal 2026 Second Quarter and First Half Results across Sales, Margins and EPS Raising Fiscal 2026 Full-Year Outlook The Estée Lauder Companies Inc. (NYSE:EL) today reported its financial results for the second quarter ended December 31, 2025. "We delivered excellent second quarter results to solidify a strong first half of fiscal 2026," said Stéphane de La Faverie, President and CEO. "In this pivotal year, Beauty Reimagined has invigorated our business as we execute the biggest operational, leadership, and cultural transformation in our history. On its one-year anniversary, we raise our fiscal 2026 outlook confident in the strength of our turnaround, even as our sec

    2/5/26 6:00:00 AM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary

    $ADBE
    $APLS
    $BLRX
    $EL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by KeyCorp

    SC 13D/A - KEYCORP /NEW/ (0000091576) ()

    1/5/94 12:00:00 AM ET
    $KEY
    Major Banks
    Finance

    Amendment: SEC Form SC 13D/A filed by Estee Lauder Companies Inc.

    SC 13D/A - ESTEE LAUDER COMPANIES INC (0001001250) (Subject)

    12/10/24 6:06:03 PM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Estee Lauder Companies Inc.

    SC 13D/A - ESTEE LAUDER COMPANIES INC (0001001250) (Subject)

    12/9/24 5:30:41 PM ET
    $EL
    Package Goods/Cosmetics
    Consumer Discretionary